Atlas Trials

Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT02055287 · COMPLETED

Trial details

NCT number
NCT02055287
Sponsor
Luye Pharma Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2013-03-01
Primary completion
2014-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.